Cargando…
Induction and Reversal of Myotonic Dystrophy Type 1 Pre-mRNA Splicing Defects by Small Molecules
The ability to control pre-mRNA splicing with small molecules could facilitate the development of therapeutics or cell-based circuits that control gene function. Myotonic dystrophy type 1 (DM1) is caused by the dysregulation of alternative pre-mRNA splicing due to sequestration of muscleblind-like 1...
Autores principales: | Childs-Disney, Jessica L., Stepniak-Konieczna, Ewa, Tran, Tuan, Yildirim, Ilyas, Park, HaJeung, Chen, Catherine Z., Hoskins, Jason, Southall, Noel, Marugan, Juan J., Patnaik, Samarjit, Zheng, Wei, Austin, Chris P., Schatz, George C., Sobczak, Krzysztof, Thornton, Charles A., Disney, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710115/ https://www.ncbi.nlm.nih.gov/pubmed/23806903 http://dx.doi.org/10.1038/ncomms3044 |
Ejemplares similares
-
Computational Investigation of RNA CUG Repeats
Responsible for Myotonic Dystrophy 1
por: Yildirim, Ilyas, et al.
Publicado: (2015) -
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy
por: Wojtkowiak-Szlachcic, Agnieszka, et al.
Publicado: (2015) -
AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1
por: Stepniak-Konieczna, Ewa, et al.
Publicado: (2020) -
Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects
por: Hoskins, Jason W., et al.
Publicado: (2014) -
Transcriptome-Wide
Studies of RNA-Targeted Small Molecules
Provide a Simple and Selective r(CUG)(exp) Degrader in Myotonic
Dystrophy
por: Gibaut, Quentin M. R., et al.
Publicado: (2023)